Malignancy chemoprevention. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Tumor Cells, Cultured Mouth Mucosa Cheek Colon Breast HT29 Cells Bronchi Epithelial Cells Prostate

Organisms13

Punicaceae Rats, Inbred F344 Garlic Milk Thistle Mice, Nude Camellia sinensis Mice, Inbred A Cactaceae Prunella Mice, Transgenic Mice, Inbred C57BL Ocimum Rosaceae

Diseases68

Neoplasms Precancerous Conditions Hematologic Neoplasms Colonic Neoplasms Lung Neoplasms Breast Neoplasms Prostatic Neoplasms Leukoplakia Skin Neoplasms Cell Transformation, Neoplastic Colorectal Neoplasms Neoplasms, Second Primary Mouth Neoplasms Adenoma Adenocarcinoma Adenomatous Polyposis Coli Carcinoma, Squamous Cell Intestinal Polyps Intestinal Neoplasms Lymphoma Mammary Neoplasms, Experimental Carcinoma, Basal Cell Head and Neck Neoplasms Respiratory Tract Neoplasms Leukoplakia, Oral Liver Neoplasms Leukemia Disease Models, Animal Disease Progression Aberrant Crypt Foci Neoplasms, Radiation-Induced Carcinoma Digestive System Neoplasms Keratosis Ovarian Neoplasms Genital Neoplasms, Female Esophageal Neoplasms Neoplasms, Experimental Pancreatic Neoplasms Keratosis, Actinic Papilloma Tongue Neoplasms Colonic Polyps Bronchial Neoplasms Carcinoma, Hepatocellular Neoplasm Invasiveness Lymphoma, Non-Hodgkin Stomach Neoplasms Thyroid Nodule Carcinoma in Situ Urinary Bladder Neoplasms Neovascularization, Pathologic Gastrointestinal Neoplasms Neoplasm Recurrence, Local Hyperplasia Metaplasia Endometrial Neoplasms Leukemia, B-Cell Barrett Esophagus Melanoma Liver Neoplasms, Experimental Lymphoma, B-Cell Multiple Myeloma Genetic Predisposition to Disease Neoplasms, Multiple Primary Adenomatous Polyps Leukemia, Lymphocytic, Chronic, B-Cell Hodgkin Disease

Chemicals and Drugs103

Anticarcinogenic Agents Sulindac Antineoplastic Agents Carcinogens Isothiocyanates Eflornithine Isotretinoin Anti-Inflammatory Agents, Non-Steroidal Catechin Azoxymethane Tea Cyclooxygenase 2 Inhibitors Retinoids Polyphenols Curcumin Etretinate Cyclooxygenase 2 Plant Extracts Tumor Markers, Biological Tamoxifen Fenretinide Chlorophyllides Pyrazoles Organoselenium Compounds Piroxicam Silymarin Thiocyanates Cyclooxygenase Inhibitors Raloxifene Finasteride Selective Estrogen Receptor Modulators 9,10-Dimethyl-1,2-benzanthracene Sulfonamides Methylnitrosourea Antioxidants Antimutagenic Agents Selenium Compounds 5-alpha Reductase Inhibitors Anethole Trithione 4-Nitroquinoline-1-oxide beta Carotene Chalcones Aspirin Azasteroids Selenomethionine Phenols Selenium Prostaglandin-Endoperoxide Synthases Flavonoids Nitrosamines Stilbenes Polyamines Carotenoids Placebos Ornithine Decarboxylase Hesperidin Benzo(a)pyrene Allyl Compounds Antineoplastic Agents, Phytogenic Urethane Tretinoin Aflatoxin B1 Pyrazines Antineoplastic Agents, Hormonal Neoplasm Proteins Biflavonoids DNA Adducts Vitamin A NF-E2-Related Factor 2 Acitretin Mesalamine NAD(P)H Dehydrogenase (Quinone)Oleanolic Acid Cyclin D1 Apigenin Tumor Suppressor Protein p53 beta Catenin Chalcone Genistein Isoenzymes Anti-Inflammatory Agents Biological Products RNA, Messenger Plant Preparations Terpenes Enzyme Inhibitors Triterpenes Dinoprostone Diosmin Vitamin E Proliferating Cell Nuclear Antigen Quercetin Pentacyclic Triterpenes DNA, Neoplasm 1,2-Dimethylhydrazine Estrogen Receptor Modulators Acetylcysteine Ki-67 Antigen Indoles Receptor, Epidermal Growth Factor Sulfides Isoflavones Sodium Selenite

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Chemoprevention Clinical Trials as Topic Phytotherapy Risk Factors Mammary Neoplasms, Experimental Treatment Outcome Immunohistochemistry Disease Models, Animal Incidence Biopsy Placebos Prognosis Drug Screening Assays, Antitumor Retrospective Studies Neoplasms, Experimental Administration, Oral Blotting, Western Risk Assessment Randomized Controlled Trials as Topic Follow-Up Studies Sensitivity and Specificity Reverse Transcriptase Polymerase Chain Reaction Markov Chains Neoplasm Staging Survival Rate Double-Blind Method Risk Administration, Topical Antineoplastic Combined Chemotherapy Protocols Biopsy, Fine-Needle Drug Evaluation, Preclinical Immunoenzyme Techniques Liver Neoplasms, Experimental Tomography, X-Ray Computed Molecular Targeted Therapy Colonoscopy Cohort Studies Biopsy, Needle Xenograft Model Antitumor Assays Prospective Studies

Psychiatry and Psychology2

Smoking Alcohol Abstinence

Phenomena and Processes20

Apoptosis Cell Proliferation Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Diet Signal Transduction Time Factors Cell Division Cell Cycle DNA Adducts Genes, APC Sensitivity and Specificity Markov Chains Risk Cell Survival Mutation Genetic Predisposition to Disease Drug Synergism Metabolic Detoxication, Phase II DNA Methylation

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Interdisciplinary Studies

Technology, Industry, Agriculture3

Tea Garlic Dietary Supplements

Information Science2

Incidence Survival Rate

Health Care18

Clinical Trials as Topic Risk Factors Treatment Outcome Tertiary Prevention Incidence Retrospective Studies Risk Assessment Randomized Controlled Trials as Topic Follow-Up Studies Sensitivity and Specificity Markov Chains Survival Rate Double-Blind Method Risk Cost-Benefit Analysis Cohort Studies Primary Prevention Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Chemoprevention Anticarcinogenic Agents Neoplasms Precancerous Conditions Hematologic Neoplasms Sulindac Antineoplastic Agents Carcinogens Isothiocyanates Eflornithine Isotretinoin Anti-Inflammatory Agents, Non-Steroidal Catechin Azoxymethane Colonic Neoplasms Lung Neoplasms Tea Cyclooxygenase 2 Inhibitors Breast Neoplasms Apoptosis Retinoids Polyphenols Prostatic Neoplasms Curcumin Leukoplakia Skin Neoplasms Etretinate Cell Transformation, Neoplastic Cell Line, Tumor Cyclooxygenase 2 Plant Extracts Tumor Markers, Biological Tamoxifen Fenretinide Chlorophyllides Colorectal Neoplasms Clinical Trials as Topic Pyrazoles Organoselenium Compounds Neoplasms, Second Primary Mouth Neoplasms Piroxicam Silymarin Thiocyanates Cyclooxygenase Inhibitors Raloxifene Finasteride Selective Estrogen Receptor Modulators Cell Proliferation Adenoma 9,10-Dimethyl-1,2-benzanthracene Sulfonamides Adenocarcinoma Methylnitrosourea Adenomatous Polyposis Coli Antioxidants Punicaceae Carcinoma, Squamous Cell Rats, Inbred F344 Antimutagenic Agents Selenium Compounds Gene Expression Regulation, Neoplastic 5-alpha Reductase Inhibitors Intestinal Polyps Phytotherapy Anethole Trithione 4-Nitroquinoline-1-oxide beta Carotene Dose-Response Relationship, Drug Diet Risk Factors Chalcones Intestinal Neoplasms Lymphoma Aspirin Azasteroids Mammary Neoplasms, Experimental Selenomethionine Carcinoma, Basal Cell Phenols Head and Neck Neoplasms Selenium Treatment Outcome Respiratory Tract Neoplasms Prostaglandin-Endoperoxide Synthases Immunohistochemistry Tertiary Prevention Signal Transduction Leukoplakia, Oral Tumor Cells, Cultured Flavonoids Liver Neoplasms Nitrosamines Leukemia Stilbenes Polyamines Disease Models, Animal Garlic Disease Progression Time Factors

No FAQ available that match "malignancy chemoprevention"